NFT
KURA icon

Nan Fung Trinity’s Kura Oncology KURA Stock Holding History

Nan Fung Trinity’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.9M Buy
1,174,880
+110,000
+10% +$1.04M 1.27% 31
2026
Q1 		$8.66M Buy
1,064,880
+100,000
+10% +$859K 0.95% 40
2025
Q4 		$10M Buy
964,880
+734,000
+318% +$7.7M 0.79% 50
2025
Q3 		$2.04M Buy
+230,880
New +$1.65M 0.2% 59

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Nan Fung Trinity's KURA Position: Q2 2026 in Review

Nan Fung Trinity increased its Kura Oncology (KURA) stake by 10% in Q2 2026, buying an estimated $1.04M and bringing the position to 1,174,880 shares worth $12.9M. The position accounts for 1.27% of the portfolio, ranked #31.

Nan Fung Trinity first reported a position in KURA in Q3 2025 and has held it in 4 quarters since. 220 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Nan Fung Trinity held 1,174,880 shares of Kura Oncology worth $12.9M as of Q2 2026.
  • Nan Fung Trinity bought 110,000 Kura Oncology shares in Q2 2026, an estimated $1.04M.
  • Kura Oncology made up 1.27% of Nan Fung Trinity's portfolio in Q2 2026, its #31 holding.
  • Nan Fung Trinity first reported a position in Kura Oncology in Q3 2025 and has held it in 4 quarters since.
  • 220 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Nan Fung Trinity's 13F filing for Q2 2026, filed 24 Jul 2026.